Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914823 · ClinicalTrials.gov registry record · Phase 1
Kisspeptin Administration in the Adult
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 256
- Enrollment target
NCT00914823: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00914823 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 256 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00914823, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 256 participants
- Enrollment target
Study Summary
The goal of this study is to learn about the role of kisspeptin in the reproductive system. Kisspeptin is a naturally occurring hormone in humans that causes the release of other hormones, including gonadotropin-releasing hormone (GnRH) in the body.
Interventions
- DRUG kisspeptin 112-121
- DRUG GnRH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2009-06-23 |
| Est. Completion | 2021-10-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00914823
The ClinicalTrials.gov registry entry for NCT00914823 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which kisspeptin 112-121 is the first listed.
NCT00914823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00914823 about?
NCT00914823 is a clinical study titled "Kisspeptin Administration in the Adult". The goal of this study is to learn about the role of kisspeptin in the reproductive system. Kisspeptin is a naturally occurring hormone in humans that causes the release of other hormones, including gonadotropin-releasing hormone (GnRH) in the body.
What is the current status of trial NCT00914823?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 256 participants. The study started on 2009-06-23. Estimated completion is 2021-10-22.
What interventions are being tested in trial NCT00914823?
The interventions under investigation include: kisspeptin 112-121 (DRUG), GnRH (DRUG).
Who is sponsoring clinical trial NCT00914823?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.